You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

CLINICAL TRIALS PROFILE FOR BUPIVACAINE; MELOXICAM


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Bupivacaine; Meloxicam

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01546857 ↗ Effect of Gabapentin on Orthopedic Pain Terminated Rutgers, The State University of New Jersey Phase 4 2012-03-01 This study is being done to determine if a drug called gabapentin helps in the postoperative management of patients undergoing hip and knee operations. The investigators wish to determine the effect of gabapentin on pain and sleep following surgery. If we can lessen a patient's pain and improve sleep, the patient will be better able to participate in their physical therapy. Gabapentin has already been shown to lessen postoperative pain when given before surgery. In healthy patients, it has also been shown to improve certain aspects of sleep. We hope to identify the effect of the drug, when given after surgery, on patients' pain and sleep.
NCT04538391 ↗ Intra Incisional Infiltration of Bupivacaine Versus Meloxicam on Post Cesarean Section Pain Relief Completed Menoufia University N/A 2019-03-03 Investigation: compare the effect of local infiltration of incision site with bupivacaine and local infiltration with meloxicam in women undergoing cesarean sections on postoperative pain relief and analgesic requirement. Condition: post cesarean sections analgesia intervention: infiltration of incision bupivacaine versus meloxicam Phase: Not applicable
NCT05188053 ↗ Periarticular Bupivacaine + Meloxicam ER Solution Versus Standard Practice During Total Knee Arthroplasty Enrolling by invitation Mayo Clinic Phase 4 2022-01-01 The purpose of this study is to compare an FDA-approved medication for post-operative pain control (HTX-011) to the standard of care institutional practice for periarticular analgesia after primary total knee arthroplasty (weight based dosing of Ropivacaine, epinephrine and ketorolac diluted with saline). We are doing this research study to find out if this new medication provides superior pain control within 72 hours following surgery.
NCT05644496 ↗ ZYNRELEF for Pain Management in Total Knee Arthroplasty Not yet recruiting Baptist Health South Florida Phase 4 2023-01-01 The goal of this randomized controlled trial is to compare opioid medication consumption after surgery for patients who have a total knee replacement. The main questions it aims to answer are: - How well does the study drug control pain in the days after surgery? - Does the study drug reduce the amount of opioid analgesic consumed after surgery? Participants in the study group will undergo a total knee replacement as planned with their surgeon. In addition, be given the study drug, Zynrelef (combination of bupivacaine and meloxicam). Researchers will compare the above to a control group who will have a total knee replace only according to usual standards to see if there are any differences in the amount of a type of pain medication (opioid analgesic) consumed in the days following surgery.
NCT05702827 ↗ Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery Not yet recruiting TriHealth Inc. Phase 3 2023-01-01 This study will compare the use of a dual-agent local analgesic (bupivacaine-meloxicam) for abdominal incisions in patients undergoing retropubic mid-urethral sling surgery to see if narcotic usage and pain are impacted.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Bupivacaine; Meloxicam

Condition Name

Condition Name for Bupivacaine; Meloxicam
Intervention Trials
Cesarean Section Pain 1
Degenerative Arthritis and Postoperative Pain 1
Degenerative Joint Disease of Hip and Knee. 1
Osteoarthritis, Knee 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Bupivacaine; Meloxicam
Intervention Trials
Pain, Postoperative 3
Surgical Wound 1
Osteoarthritis, Knee 1
Osteoarthritis, Hip 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Bupivacaine; Meloxicam

Trials by Country

Trials by Country for Bupivacaine; Meloxicam
Location Trials
United States 5
Egypt 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Bupivacaine; Meloxicam
Location Trials
Pennsylvania 1
Ohio 1
Florida 1
Minnesota 1
New Jersey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Bupivacaine; Meloxicam

Clinical Trial Phase

Clinical Trial Phase for Bupivacaine; Meloxicam
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Bupivacaine; Meloxicam
Clinical Trial Phase Trials
Enrolling by invitation 2
Not yet recruiting 2
Completed 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Bupivacaine; Meloxicam

Sponsor Name

Sponsor Name for Bupivacaine; Meloxicam
Sponsor Trials
Menoufia University 1
Mayo Clinic 1
Baptist Health South Florida 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Bupivacaine; Meloxicam
Sponsor Trials
Other 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.